Total Payments
$6,606
2024 Payments
$1,026
Companies
26
Transactions
344
Medicare Patients
1,096
Medicare Billing
$213,052
Payment Breakdown by Category
Food & Beverage$6,464 (97.8%)
Other$125.00 (1.9%)
Education$17.05 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,464 | 339 | 97.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 1.9% |
| Education | $17.05 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,112 | 43 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $985.28 | 56 | $0 (2022) |
| Allergan, Inc. | $871.29 | 61 | $0 (2020) |
| ABBVIE INC. | $595.99 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $496.21 | 28 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $453.02 | 39 | $0 (2024) |
| Axsome Therapeutics, Inc. | $297.36 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $288.16 | 6 | $0 (2022) |
| Alkermes, Inc. | $205.54 | 10 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $155.07 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,026 | 40 | Otsuka America Pharmaceutical, Inc. ($213.54) |
| 2023 | $1,219 | 76 | Axsome Therapeutics, Inc. ($252.98) |
| 2022 | $740.21 | 42 | ABBVIE INC. ($141.49) |
| 2021 | $322.14 | 25 | AbbVie Inc. ($174.50) |
| 2020 | $536.25 | 26 | Neurocrine Biosciences, Inc. ($233.38) |
| 2019 | $324.19 | 18 | Allergan Inc. ($218.44) |
| 2018 | $1,250 | 50 | Otsuka America Pharmaceutical, Inc. ($370.93) |
| 2017 | $1,188 | 67 | Sunovion Pharmaceuticals Inc. ($519.31) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 4 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Neuroscience | ||||||
| 08/02/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Education | In-kind items and services | $5.17 | General |
| Category: PSYCHOLOGY | ||||||
| 06/28/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.78 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ANTI-ANXIETY | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.67 | General |
| Category: PSYCHOLOGY | ||||||
| 05/31/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $1.56 | General |
| Category: PSYCHOLOGY | ||||||
| 05/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 05/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $5.78 | General |
| Category: PSYCHOLOGY | ||||||
| 05/10/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/09/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.46 | General |
| Category: PSYCHOLOGY | ||||||
| 05/04/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Neuroscience | ||||||
| 05/03/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.86 | General |
| Category: PSYCHOLOGY | ||||||
| 05/01/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CNS | ||||||
| 04/26/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: PSYCHOLOGY | ||||||
| 04/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.58 | General |
| Category: PSYCHOLOGY | ||||||
| 04/12/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.67 | General |
| Category: PSYCHOLOGY | ||||||
| 04/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $8.41 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 194 | 364 | $52,330 | $29,256 |
| 2022 | 5 | 209 | 416 | $51,075 | $28,339 |
| 2021 | 8 | 315 | 733 | $96,680 | $59,376 |
| 2020 | 7 | 378 | 1,313 | $203,401 | $96,082 |
Total Patients
1,096
Total Services
2,826
Medicare Billing
$213,052
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 167 | $23,275 | $14,024 | 60.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 69 | $13,195 | $7,822 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 69 | $6,900 | $3,512 | 50.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $4,855 | $2,173 | 44.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 35 | 41 | $4,105 | $1,724 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 244 | $24,280 | $13,666 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 77 | $10,680 | $6,629 | 62.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 28 | 28 | $7,700 | $3,323 | 43.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 43 | 54 | $5,295 | $2,889 | 54.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,120 | $1,832 | 58.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 269 | $25,340 | $17,055 | 67.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 195 | $27,300 | $15,916 | 58.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 43 | $10,320 | $6,648 | 64.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 46 | 46 | $12,365 | $6,615 | 53.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 69 | $8,290 | $5,877 | 70.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 30 | 39 | $4,875 | $3,278 | 67.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 47 | $5,640 | $2,671 | 47.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 21 | 25 | $2,550 | $1,316 | 51.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 555 | $68,268 | $32,076 | 47.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 86 | 381 | $72,045 | $31,972 | 44.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 65 | 75 | $22,750 | $11,472 | 50.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 173 | $17,300 | $9,071 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 50 | 60 | $9,268 | $5,059 | 54.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 29 | 31 | $7,389 | $3,571 | 48.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 27 | $3,411 | $1,718 | 50.4% |
About Dr. Sofia Grewal, MD
Dr. Sofia Grewal, MD is a Psychiatry healthcare provider based in St Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265441299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sofia Grewal, MD has received a total of $6,606 in payments from pharmaceutical and medical device companies, with $1,026 received in 2024. These payments were reported across 344 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,464).
As a Medicare-enrolled provider, Grewal has provided services to 1,096 Medicare beneficiaries, totaling 2,826 services with total Medicare billing of $213,052. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location St Louis, MO
- Active Since 08/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1265441299
Products in Payments
- VRAYLAR (Drug) $1,239
- REXULTI (Drug) $1,001
- LATUDA (Drug) $985.28
- Auvelity (Drug) $297.36
- INGREZZA (Drug) $288.16
- QELBREE (Drug) $271.96
- INVEGA SUSTENNA (Drug) $220.52
- ABILIFY MAINTENA (Drug) $189.92
- SPRAVATO (Drug) $189.69
- ARISTADA (Drug) $189.36
- Qelbree (Drug) $181.06
- CAPLYTA (Drug) $171.21
- DALVANCE (Drug) $125.01
- GEMTESA (Drug) $125.00
- QUVIVIQ (Drug) $106.67
- Fanapt (Drug) $103.62
- UBRELVY (Drug) $103.06
- INVEGA TRINZA (Drug) $86.00
- JORNAY PM (Drug) $83.62
- MOVANTIK (Drug) $80.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in St Louis
Dr. Thomas Nowotny, Md, MD
Psychiatry — Payments: $22,748
Psychiatry $22,748
Dr. Ernest Graypel, Md, MD
Psychiatry — Payments: $8,404
Psychiatry $8,404
Dr. Dale Anderson, M.d, M.D
Psychiatry — Payments: $5,106
Psychiatry $5,106
Srinivas Chilakamarri, Md, MD
Psychiatry — Payments: $932.83
Psychiatry $932.83
Dr. Ahmad Ardekani, Md, MD
Psychiatry — Payments: $328.74
Psychiatry $328.74
Dr. Garry Vickar, Md, MD
Psychiatry — Payments: $101.19
Psychiatry $101.19